Edition:
United States

Lee's Pharmaceutical Holdings Ltd (0950.HK)

0950.HK on Hong Kong Stock

6.32HKD
21 Jul 2017
Change (% chg)

HK$0.07 (+1.12%)
Prev Close
HK$6.25
Open
HK$6.25
Day's High
HK$6.35
Day's Low
HK$6.20
Volume
346,000
Avg. Vol
1,077,000
52-wk High
HK$7.88
52-wk Low
HK$6.02

Latest Key Developments (Source: Significant Developments)

Lee's Pharmaceutical reports qtrly profit attributable HK$46.4 mln
Wednesday, 31 May 2017 04:32am EDT 

May 31 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>:Qtrly revenue HK$226.2 million versus HK$225.5 million.Qtrly profit attributable to owners of company HK$46.4 million versus HK$53.1 million.Board does not recommend payment of dividend for three months ended 31 March 2017.  Full Article

Lee's Pharmaceutical says shareholder Essetifin S.P.A. decreased its stake in co
Sunday, 2 Apr 2017 08:19pm EDT 

Lee's Pharmaceutical Holdings Ltd <0950.HK> :Its shareholder Essetifin S.P.A. decreased its stake from approximately 24.07% to approximately 9.63% in co.  Full Article

Lee's Pharmaceutical says shareholder Essetifin S.P.A. decreased its stake in co<0950.HK>
Sunday, 2 Apr 2017 06:52pm EDT 

Lee's Pharmaceutical Holdings Ltd <0950.HK> :Its shareholder Essetifin S.P.A. decreased its stake from approximately 24.07% to approximately 9.63% in co.  Full Article

Lee's Pharmaceutical says unit entered into the shareholder loan agreement<0950.HK>
Monday, 13 Jun 2016 07:41am EDT 

Lee's Pharmaceutical Holdings Ltd <0950.HK>: Says unit entered into the shareholder loan agreement . Lee's International agrees to advance shareholder loan in principle amount of hk$10 million to cof at an interest rate of 4% per annum .  Full Article

BRIEF-Lee's Pharmaceutical reports qtrly profit attributable HK$46.4 mln

* Qtrly profit attributable to owners of company HK$46.4 million versus HK$53.1 million